MIRM [NASD]
Mirum Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-1.14 Insider Own0.70% Shs Outstand36.87M Perf Week-4.93%
Market Cap702.52M Forward P/E- EPS next Y-2.83 Insider Trans-56.53% Shs Float35.24M Perf Month-18.72%
Income-41.70M PEG- EPS next Q-0.97 Inst Own94.70% Short Float / Ratio4.81% / 4.16 Perf Quarter-24.53%
Sales52.30M P/S13.43 EPS this Y32.30% Inst Trans14.78% Short Interest1.69M Perf Half Y-25.13%
Book/sh4.85 P/B3.89 EPS next Y29.20% ROA-13.50% Target Price55.88 Perf Year39.20%
Cash/sh4.99 P/C3.79 EPS next 5Y- ROE-32.80% 52W Range12.95 - 30.55 Perf YTD18.43%
Dividend- P/FCF- EPS past 5Y- ROI-54.50% 52W High-38.16% Beta1.40
Dividend %- Quick Ratio4.10 Sales past 5Y- Gross Margin81.30% 52W Low45.81% ATR1.43
Employees194 Current Ratio4.20 Sales Q/Q276.00% Oper. Margin-66.20% RSI (14)42.05 Volatility5.75% 6.85%
OptionableYes Debt/Eq0.00 EPS Q/Q34.10% Profit Margin-79.70% Rel Volume0.90 Prev Close18.28
ShortableYes LT Debt/Eq0.00 EarningsNov 09 BMO Payout- Avg Volume407.48K Price18.89
Recom1.50 SMA20-6.88% SMA50-8.53% SMA200-17.43% Volume365,765 Change3.34%
Sep-01-22Initiated Citigroup Buy $38
Sep-20-21Initiated JP Morgan Overweight $30
Aug-07-20Upgrade Raymond James Outperform → Strong Buy $28 → $48
Aug-03-20Initiated H.C. Wainwright Buy $52
Jul-31-20Initiated Piper Sandler Overweight $77
Jun-25-20Initiated Robert W. Baird Outperform $30
Aug-12-19Initiated ROTH Capital Buy $33
Aug-12-19Initiated Raymond James Outperform $28
Aug-12-19Initiated Guggenheim Buy $18
Aug-12-19Initiated Evercore ISI Outperform
Show Previous Ratings
Nov-29-22 07:30AM
Nov-18-22 08:50AM
Nov-09-22 08:45AM
07:30AM
Nov-07-22 01:00PM
10:00AM Loading…
Nov-02-22 10:00AM
Nov-01-22 04:05PM
Oct-31-22 07:13PM
03:30PM
Oct-26-22 11:05AM
Oct-24-22 08:30AM
Oct-18-22 08:30AM
Oct-14-22 08:05AM
Oct-12-22 08:30AM
Oct-10-22 10:00PM
08:30AM Loading…
Oct-05-22 08:30AM
Oct-01-22 08:38AM
Sep-12-22 02:30AM
Sep-04-22 09:16AM
Sep-02-22 11:19AM
Aug-30-22 04:01PM
Aug-26-22 06:20PM
Aug-12-22 04:30PM
Aug-10-22 11:59PM
Aug-09-22 09:33PM
04:11PM
Aug-08-22 06:33AM
Aug-04-22 05:55PM
04:01PM
Aug-02-22 10:01AM
10:02AM Loading…
Jul-28-22 10:02AM
09:00AM
Jul-27-22 06:19AM
Jul-08-22 09:00PM
Jun-24-22 08:00AM
03:00AM
Jun-13-22 08:30AM
Jun-10-22 08:00PM
Jun-06-22 08:30AM
May-23-22 10:06AM
08:30AM
May-18-22 06:30PM
May-10-22 08:05PM
May-05-22 09:25AM
08:00AM
May-02-22 04:05PM
Apr-18-22 08:31AM
Apr-08-22 06:30PM
Mar-10-22 10:14PM
Mar-09-22 04:00PM
Mar-02-22 08:38AM
08:30AM
Feb-17-22 09:27AM
Feb-10-22 07:00PM
Feb-09-22 08:30AM
Jan-14-22 09:38AM
Jan-11-22 08:00AM
Jan-10-22 08:30PM
Jan-04-22 08:30AM
Dec-15-21 08:30AM
Dec-13-21 08:30AM
Dec-06-21 08:30AM
Dec-01-21 05:03AM
Nov-30-21 11:53AM
Nov-22-21 08:30AM
Nov-17-21 08:30AM
Nov-15-21 05:25PM
04:01PM
12:30PM
Nov-08-21 04:05PM
Nov-01-21 01:12PM
08:30AM
Sep-29-21 05:45PM
01:19PM
01:00PM
Sep-22-21 08:55AM
Sep-21-21 11:00AM
08:00AM
Sep-13-21 06:45AM
Sep-10-21 05:30PM
Sep-02-21 05:30PM
Aug-26-21 08:53AM
Aug-19-21 05:30PM
Aug-10-21 07:00PM
Aug-05-21 06:35PM
04:02PM
Jul-29-21 04:00PM
Jul-27-21 06:59AM
Jul-26-21 08:00PM
Jul-12-21 06:00PM
05:41AM
Jun-24-21 04:05PM
Jun-23-21 09:00AM
Jun-16-21 09:00AM
Jun-10-21 05:30PM
Jun-07-21 09:00AM
Jun-03-21 10:10AM
May-26-21 09:00AM
May-12-21 04:47AM
May-10-21 09:00PM
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It also develops Volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Mirum Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Foster City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
O'Donnell NiallDirectorNov 15Sale19.6993,7701,846,0221,621,118Nov 15 08:02 PM
O'Donnell NiallDirectorNov 14Sale19.6032,109629,4231,714,888Nov 15 08:02 PM
O'Donnell NiallDirectorNov 11Sale19.99174,1213,481,4101,746,997Nov 15 08:02 PM
Flynn James E10% OwnerJun 06Sale25.0138,478962,2561,540,190Jun 08 07:25 PM